Erion; Mark D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Erion; Mark D..The latest application filed is for "thyromimetics for the treatment of fatty liver diseases".
Company Profile
2.53.38
- Erion; Mark D. - Del Mar CA
- Erion; Mark D. - Livingston NJ
Patent Activity
| Patent | Date |
|---|---|
| Thyromimetics for the treatment of fatty liver diseases Grant 10,925,885 - Cable , et al. February 23, 2 | 2021-02-23 |
| Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof Grant 10,709,718 - Reddy , et al. | 2020-07-14 |
| Thyromimetics For The Treatment Of Fatty Liver Diseases App 20190083515 - Cable; Edward E. ; et al. | 2019-03-21 |
| Activators of glucokinase Grant 10,174,062 - Tian , et al. J | 2019-01-08 |
| Thyromimetics for the treatment of fatty liver diseases Grant 10,130,643 - Cable , et al. November 20, 2 | 2018-11-20 |
| Inhibitors Of Diacylglycerol O-acyltransferase 1 (dgat-1) And Uses Thereof App 20180303856 - Reddy; K. Raja ; et al. | 2018-10-25 |
| Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof Grant 10,034,891 - Reddy , et al. July 31, 2 | 2018-07-31 |
| Thyromimetics for the Treatment of Fatty Liver Diseases App 20170112864 - CABLE; Edward E. ; et al. | 2017-04-27 |
| Novel Activators Of Glucokinase App 20170096440 - Tian; Feng ; et al. | 2017-04-06 |
| Activators of glucokinase Grant 9,522,926 - Tian , et al. December 20, 2 | 2016-12-20 |
| Inhibitors Of Diacylglycerol O-acyltransferase 1 (dgat-1) And Uses Thereof App 20160263132 - REDDY; K. RAJA ; et al. | 2016-09-15 |
| Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof Grant 9,340,566 - Reddy , et al. May 17, 2 | 2016-05-17 |
| Inhibitors Of Diacylglycerol O-acyltransferase 1 (dgat-1) And Uses Thereof App 20150166590 - REDDY; K. RAJA ; et al. | 2015-06-18 |
| Novel Activators Of Glucokinase App 20150119365 - Tian; Feng ; et al. | 2015-04-30 |
| Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof Grant 8,962,618 - Reddy , et al. February 24, 2 | 2015-02-24 |
| Activators of glucokinase Grant 8,940,927 - Tian , et al. January 27, 2 | 2015-01-27 |
| Phosphorus-containing prodrugs Grant 8,664,195 - Erion , et al. March 4, 2 | 2014-03-04 |
| Inhibitors of Diacylglycerol O-Acyltransferase 1 (DGAT-1) and Uses Thereof App 20120270842 - REDDY; K. RAJA ; et al. | 2012-10-25 |
| Novel Phosphorus-containing Prodrugs App 20120093729 - ERION; Mark D. ; et al. | 2012-04-19 |
| Phosphorus-containing prodrugs Grant 8,080,536 - Erion , et al. December 20, 2 | 2011-12-20 |
| Novel Activators Of Glucokinase App 20110294758 - Tian; Feng ; et al. | 2011-12-01 |
| Novel Phosphorus-containing Prodrugs App 20110009356 - ERION; Mark D. ; et al. | 2011-01-13 |
| Phosphorus-containing thyromimetics Grant 7,829,552 - Erion , et al. November 9, 2 | 2010-11-09 |
| Phosphorus-containing prodrugs Grant 7,816,345 - Erion , et al. October 19, 2 | 2010-10-19 |
| Novel Phosphorus-Containing Thyromimetics App 20100081634 - Erion; Mark D. ; et al. | 2010-04-01 |
| 2'-C-methyl nucleoside derivatives Grant 7,666,855 - Reddy , et al. February 23, 2 | 2010-02-23 |
| Thyromimetics for the Treatment of Fatty Liver Diseases App 20090232879 - Cable; Edward E. ; et al. | 2009-09-17 |
| Combination of FBPase Inhibitors and Antidiabetic Agents Useful for the Treatment of Diabetes App 20090197836 - van Poelje; Paul D. ; et al. | 2009-08-06 |
| Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes Grant 7,563,774 - van Poelje , et al. July 21, 2 | 2009-07-21 |
| Cytarabine monophosphate prodrugs Grant 7,553,826 - Boyer , et al. June 30, 2 | 2009-06-30 |
| Novel Nucleoside Derivatives App 20090131370 - Reddy; K. Raja ; et al. | 2009-05-21 |
| Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives App 20090118223 - Erion; Mark D. ; et al. | 2009-05-07 |
| Novel Phosphorus-Containing Thyromimetics App 20090118236 - Erion; Mark D. ; et al. | 2009-05-07 |
| Phosphorus-containing thyromimetics Grant 7,514,419 - Erion , et al. April 7, 2 | 2009-04-07 |
| Novel Phosphinic Acid-Containing Thyromimetics App 20090028925 - Erion; Mark D. ; et al. | 2009-01-29 |
| Novel Phosphorus-Containing Prodrugs App 20080125605 - Erion; Mark D. ; et al. | 2008-05-29 |
| Prodrugs for phosphorus-containing compounds Grant 7,351,399 - Erion , et al. April 1, 2 | 2008-04-01 |
| Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase App 20080015195 - Dang; Qun ; et al. | 2008-01-17 |
| Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of Diabetes App 20080004226 - Erion; Mark D. ; et al. | 2008-01-03 |
| Heteroaromatic inhibitors of fructose 1,6-bisphosphatase Grant 7,312,219 - Dang , et al. December 25, 2 | 2007-12-25 |
| Prodrugs for liver specific drug delivery Grant 7,303,739 - Erion , et al. December 4, 2 | 2007-12-04 |
| Novel phosphorus-containing prodrugs App 20070249564 - Erion; Mark D. ; et al. | 2007-10-25 |
| Purine inhibitors of fructose-1,6-bisphosphatase Grant 7,285,543 - Dang , et al. October 23, 2 | 2007-10-23 |
| Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase App 20070232571 - Dang; Qun ; et al. | 2007-10-04 |
| Novel 2'-C methyl nucleoside derivatives App 20070179114 - Erion; Mark D. ; et al. | 2007-08-02 |
| Phosphonic acid based prodrugs of PMEA and its analogues Grant 7,214,668 - Reddy , et al. May 8, 2 | 2007-05-08 |
| Phosphorus-containing prodrugs Grant 7,205,404 - Erion , et al. April 17, 2 | 2007-04-17 |
| Novel 2'-C-methyl nucleoside derivatives App 20070042989 - Reddy; K. Raja ; et al. | 2007-02-22 |
| Novel cytarabine monophosphate prodrugs App 20070037774 - Boyer; Serge ; et al. | 2007-02-15 |
| Cytarabine monophosphate prodrugs Grant 7,151,092 - Boyer , et al. December 19, 2 | 2006-12-19 |
| Novel phosphorus-containing thyromimetics App 20060046980 - Erion; Mark D. ; et al. | 2006-03-02 |
| Novel-prodrugs for phosphorus-containing compounds App 20050288240 - Erion, Mark D. ; et al. | 2005-12-29 |
| Novel purine inhibitors of fructose-1,6-bisphosphatase App 20050277619 - Dang, Qun ; et al. | 2005-12-15 |
| Purine inhibitors of fructose-1,6-bisphosphatase Grant 6,967,193 - Dang , et al. November 22, 2 | 2005-11-22 |
| Prodrugs for phosphorus-containing compounds Grant 6,946,115 - Erion , et al. September 20, 2 | 2005-09-20 |
| Novel 2'-C-methyl nucleoside derivatives App 20050182252 - Reddy, K. Raja ; et al. | 2005-08-18 |
| Prodrugs for liver specific drug delivery App 20050101775 - Erion, Mark D. ; et al. | 2005-05-12 |
| Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes App 20040167178 - Erion, Mark D. ; et al. | 2004-08-26 |
| Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes Grant 6,756,360 - Erion , et al. June 29, 2 | 2004-06-29 |
| Prodrugs for liver specific drug delivery Grant 6,752,981 - Erion , et al. June 22, 2 | 2004-06-22 |
| Novel cytarabine monophosphate prodrugs App 20040092476 - Boyer, Serge ; et al. | 2004-05-13 |
| Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase App 20040058892 - Dang, Qun ; et al. | 2004-03-25 |
| Novel phosphonic acid based prodrugs of PMEA and its analogues App 20030229225 - Reddy, K. Raja ; et al. | 2003-12-11 |
| Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes App 20030073728 - van Poelje, Paul D. ; et al. | 2003-04-17 |
| Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase Grant 6,489,476 - Dang , et al. De | 2002-12-03 |
| Benzimidazole inhibitors of fructose 1,6-bisphosphatase Grant 6,399,782 - Kasibhatla , et al. June 4, 2 | 2002-06-04 |
| Novel prodrugs for phosphorus-containing compounds App 20020052345 - Erion, Mark D. ; et al. | 2002-05-02 |
| Prodrugs phosphorus-containing compounds Grant 6,312,662 - Erion , et al. November 6, 2 | 2001-11-06 |
| Indole and azaindole inhibitors of Fructose-1,6-biphosphatase Grant 6,294,672 - Reddy , et al. September 25, 2 | 2001-09-25 |
| Purine inhibitors of fructose 1,6-bisphosphatase Grant 6,284,748 - Dang , et al. September 4, 2 | 2001-09-04 |
| Benzimidazole inhibitors of fructose 1,6-bisphosphatase Grant 6,110,903 - Kasibhatla , et al. August 29, 2 | 2000-08-29 |
| Indole and azaindole inhibitors of fructose-1,6-bisphosphatase Grant 6,054,587 - Reddy , et al. April 25, 2 | 2000-04-25 |
| Adenosine kinase inhibitors Grant 5,864,033 - Browne , et al. January 26, 1 | 1999-01-26 |
| Water soluble adenosine kinase inhibitors Grant 5,795,977 - Ugarkar , et al. August 18, 1 | 1998-08-18 |
| Method and compounds for diagnosing coronary artery disease Grant 5,775,329 - Metzner , et al. July 7, 1 | 1998-07-07 |
| Orally active adenosine kinase inhibitors Grant 5,763,597 - Ugarkar , et al. June 9, 1 | 1998-06-09 |
| C-4' modified adenosine kinase inhibitors Grant 5,763,596 - Boyer , et al. June 9, 1 | 1998-06-09 |
| Inhibitors of adenosine monophosphate deaminase Grant 5,731,432 - Erion , et al. March 24, 1 | 1998-03-24 |
| Water soluble adenosine kinase inhibitors Grant 5,726,302 - Ugarkar , et al. March 10, 1 | 1998-03-10 |
| Orally active adenosine kinase inhibitors Grant 5,721,356 - Ugarkar , et al. February 24, 1 | 1998-02-24 |
| C-4' modified adenosine kinase inhibitors Grant 5,674,998 - Boyer , et al. October 7, 1 | 1997-10-07 |
| Methods for treating adenosine kinase related conditions Grant 5,646,128 - Firestein , et al. July 8, 1 | 1997-07-08 |
| 9-subtituted-8-unsubstituted-9-deazaguanines Grant 5,565,463 - Secrist, III , et al. October 15, 1 | 1996-10-15 |
| Lyxofuranosyl analogues of adenosine Grant 5,506,347 - Erion , et al. April 9, 1 | 1996-04-09 |
| Phosphono/biaryl substituted dipetide derivatives Grant 5,294,632 - Erion , et al. March 15, 1 | 1994-03-15 |
| Phosphono/biaryl substituted dipeptide derivatives Grant 5,155,100 - Erion , et al. October 13, 1 | 1992-10-13 |
Company Registrations
| SEC | 0001292403 | Erion Mark D |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 